Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques).
Riggi M, Ruffie P, Voisin S, Monnet I, de Cremoux H, Saltiel JC, Martin M, Vergne L, Huet J, Cvitkovic E. Riggi M, et al. Among authors: monnet i. Eur J Cancer. 1991;27(10):1238-42. doi: 10.1016/0277-5379(91)90089-v. Eur J Cancer. 1991. PMID: 1659842 Clinical Trial.
Cisplatin and continuous infusion vindesine and 5-fluorouracil in non-small cell lung cancer (NSCLC) (ATTIT 002). ATTIT (Association pour le Traitment des Tumeurs Intra-Thoraciques).
Riggi M, Cvitkovic E, de Cremoux H, Ruffie P, Monnet I, Voisin S, Villalobos W, Azli N, Saltiel JC. Riggi M, et al. Among authors: monnet i. Eur J Cancer. 1993;29A(13):1914-5. doi: 10.1016/0959-8049(93)90558-w. Eur J Cancer. 1993. PMID: 8260254 Clinical Trial. No abstract available.
200 results